Five years after their pandemic-era success, BioNTech and Moderna are racing to transform promising medical breakthroughs ...
18don MSN
Doctors call Moderna, Merck's cancer vaccine data a major advancement — even as stocks fall
Six melanoma specialists said the Moderna and Merck vaccine results represent a clinically meaningful advance in melanoma treatment.
Key TakeawaysModerna jumped 9% after Piper Sandler raised its price target to $305 from $230, following Friday’s ...
The Motley Fool on MSN
Moderna's Q3 Numbers May Have Seemed Impressive, but They Aren't Enough to Make the Stock a Buy
Revenue for the vaccine maker rose sharply in the third quarter, but it was largely due to COVID sales, which have been down ...
Nov 6 (Reuters) - Moderna lifted its full-year revenue forecast on Friday, after strong international demand for its COVID-19 ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Personalized cancer vaccines are getting closer to market. Merck and Moderna just showed successful manufacturing in a large ...
Hughes is a partner with the law firm Epstein Becker Green and a professorial lecturer in law at the George Washington University Law School. He previously served as vice president of public policy at ...
Moderna's cancer vaccine has been the big story this year, but its latest quarter showed the rest of its business is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results